Welcome to the detailed analysis for endpts.com. This domain is officially recognized as Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.. According to their official web presence, their primary focus is: "Biotech and pharma business news, with a focus on the science, people and money that drive the industry.".
"MILAN — As more GLP-1-based drugs reach late-stage trials and post stronger and stronger weight loss effects, companies that want to enter the market are looking for differentiating ..."
"Biohaven has found a commercial partner for its late-stage epilepsy drug."
"Egetis Therapeutics has secured US approval of its drug for a rare disease that shortens life expectancy to 35 years."
"After months of hunting for potential buyers of multiple manufacturing sites in Germany, BioNTech said it will close these facilities after being unable to lock in a deal."
By comparing endpts.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to endpts.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of October 4, 2026, endpts.com holds an estimated domain authority score of 74/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to endpts.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for endpts.com: